Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening
Prostate cancer screening by PSA testing remains controversial, particularly in the elderly. Practice guidelines from most clinical societies suggest discontinuing PSA screening at age 70 while the USPSTF recommends against screening at any age. Recent reports have demonstrated an increased incidenc...
Main Authors: | Ridwan Alam, Jeffrey J. Tosoian, Ofobuike Okani, Ashley E. Ross, Milena Vuica-Ross |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442016302534 |
Similar Items
-
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01) -
Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01) -
Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer
by: Jibril Oyekunle Bello
Published: (2017-05-01) -
Free PSA: A better molecular marker than total PSA for breast cancer
by: Rachita Nanda
Published: (2014-10-01) -
Total PSA and free PSA in patients with severe liver dysfunction
by: Rama Devi Mittal, et al.
Published: (2003-01-01)